Farther Finance Advisors’s Sunshine Biopharma SBFM Stock Holding History

Farther Finance Advisors’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Buy	+1	New	+$6	﹤0.01%	5962
2026 Q1	–	Hold	0	–	–	–	5748
2025 Q4	–	Hold	0	–	–	–	5449
2025 Q3	–	Hold	0	–	–	–	4957
2025 Q2	–	Hold	0	–	–	–	4487
2025 Q1	–	Hold	0	–	–	–	4250
2024 Q4	–	Hold	0	–	–	–	3985
2024 Q3	–	Hold	0	–	–	–	3973

Other funds holding SBFM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

SFG

Strive Financial Group Carmel, Indiana $230M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Farther Finance Advisors's SBFM Position: Q2 2026 in Review

Farther Finance Advisors opened a new position in Sunshine Biopharma (SBFM) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #5962 among its holdings.

9 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

Farther Finance Advisors held 1 share of Sunshine Biopharma worth $2 as of Q2 2026.
Sunshine Biopharma was a new Farther Finance Advisors position in Q2 2026.
Sunshine Biopharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5962 holding.
9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.